- Home
- SPIR vs CATX Comparison
SPIR vs CATX Comparison
Compare SPIR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPIR | CATX |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 497.9M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SPIR | CATX |
|---|---|---|
| Price | $20.51 | $4.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $14.20 | $12.11 |
| AVG Volume (30 Days) | 802.2K | ★ 1.3M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.98 | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $110,451,000.00 | N/A |
| Revenue This Year | $8.69 | $12.71 |
| Revenue Next Year | $29.32 | N/A |
| P/E Ratio | $10.45 | ★ N/A |
| Revenue Growth | ★ 13.15 | N/A |
| 52 Week Low | $6.60 | $1.74 |
| 52 Week High | $16.55 | $6.16 |
Technical Indicators
Market Signals| Indicator | SPIR | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 81.76 | 45.85 |
| Support Level | $8.05 | $3.24 |
| Resistance Level | N/A | $4.64 |
| Average True Range (ATR) | 1.68 | 0.33 |
| MACD | 0.62 | -0.01 |
| Stochastic Oscillator | 98.67 | 48.65 |
Price Performance
Historical ComparisonAbout SPIR Spire Global Inc.
Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.